Products & Benefits
Axolotl DualGraft™ is a bi-layered dehydrated human amnion membrane allograft (dhAM) derived from the amniotic lining of the placenta. Axolotl DualGraft™ is indicated as a barrier and selective membrane but has properties known to advance soft tissue repair and reconstruction. Axolotl DualGraft™ simplifies the application process by positioning the epithelial surfaces facing outwards, eliminating application placement limitations. Axolotl DualGraft™ is marketed under Section 361 of the PHS act and regulated under 21 CFR Part 1271.
The amniotic components used in Axolotl DualGraft™ create a natural 3-D extracellular matrix scaffold for cellular attachment and creates an environment to allow for cell migration. Axolotl Dual Graft™ is processed through minimally manipulated techniques. This type of processing retains the qualities of the native ECM allowing Axolotl DualGraft™ to aid in cellular chemotaxis and ingrowth.
Proteins found in Axolotl DualGraft™ include:
• Collagen I, Ill, IV, V and VII
The donor tissue is recovered and processed under sterile conditions, in accordance with all FDA guidelines and quality assurance standards in a controlled environment. Axolotl DualGraft™ allograft tissue products are terminally irradiated in the final package. Axolotl DualGraft™ is only intended for use in the domestic United States.